The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020

2.

Matsuda

LA

,

Lolait

SJ

,

Brownstein

MJ

,

Young

AC

,

Bonner

TI

.

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

.

Nature

.

1990

Aug

;

346

(

6284

):

561

–

4

.

[PubMed]

0028-0836

3.

Munro

S

,

Thomas

KL

,

Abu-Shaar

M

.

Molecular characterization of a peripheral receptor for cannabinoids

.

Nature

.

1993

Sep

;

365

(

6441

):

61

–

5

.

[PubMed]

0028-0836

4.

Lu

HC

,

Mackie

K

.

An Introduction to the Endogenous Cannabinoid System

.

Biol Psychiatry

.

2016

Apr

;

79

(

7

):

516

–

25

.

[PubMed]

1873-2402

5.

Di Marzo

V

.

New approaches and challenges to targeting the endocannabinoid system

.

Nat Rev Drug Discov

.

2018

Sep

;

17

(

9

):

623

–

39

.

[PubMed]

1474-1784

6.

Velasco

G

,

Sánchez

C

,

Guzmán

M

.

Towards the use of cannabinoids as antitumour agents

.

Nat Rev Cancer

.

2012

May

;

12

(

6

):

436

–

44

.

[PubMed]

1474-1768

7.

Klein

TW

.

Cannabinoid-based drugs as anti-inflammatory therapeutics

.

Nat Rev Immunol

.

2005

May

;

5

(

5

):

400

–

11

.

[PubMed]

1474-1733

8.

Akdis

CA

,

Arkwright

PD

,

Brüggen

MC

,

Busse

W

,

Gadina

M

,

Guttman-Yassky

E

, et al.

Type 2 immunity in the skin and lungs

.

Allergy

.

2020

Apr

.

[PubMed]

1398-9995

9.

Palomares

O

,

Akdis

M

,

Martín-Fontecha

M

,

Akdis

CA

.

Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells

.

Immunol Rev

.

2017

Jul

;

278

(

1

):

219

–

36

.

[PubMed]

1600-065X

10.

Agache

I

,

Annesi-Maesano

I

,

Bonertz

A

,

Branca

F

,

Cant

A

,

Fras

Z

, et al.

Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases

.

Allergy

.

2019

Nov

;

74

(

11

):

2064

–

76

.

[PubMed]

1398-9995

11.

Verschoor

D

,

von Gunten

S

.

Allergy and Atopic Diseases: An Update on Experimental Evidence

.

Int Arch Allergy Immunol

.

2019

;

180

(

4

):

235

–

43

.

[PubMed]

1423-0097

12.

Senti

G

,

Freiburghaus

AU

,

Larenas-Linnemann

D

,

Hoffmann

HJ

,

Patterson

AM

,

Klimek

L

, et al.

Intralymphatic Immunotherapy: Update and Unmet Needs

.

Int Arch Allergy Immunol

.

2019

;

178

(

2

):

141

–

9

.

[PubMed]

1423-0097

13.

Bonertz

A

,

Roberts

GC

,

Hoefnagel

M

,

Timon

M

,

Slater

JE

,

Rabin

RL

, et al.

Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

.

Allergy

.

2018

Jan

;

73

(

1

):

64

–

76

.

[PubMed]

1398-9995

14.

Braun

A

,

Engel

T

,

Aguilar-Pimentel

JA

,

Zimmer

A

,

Jakob

T

,

Behrendt

H

, et al.

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors

.

Immunobiology

.

2011

Apr

;

216

(

4

):

466

–

76

.

[PubMed]

1878-3279

15.

Gaffal

E

,

Cron

M

,

Glodde

N

,

Tüting

T

.

Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors

.

Allergy

.

2013

Aug

;

68

(

8

):

994

–

1000

.

[PubMed]

1398-9995

16.

Frei

RB

,

Luschnig

P

,

Parzmair

GP

,

Peinhaupt

M

,

Schranz

S

,

Fauland

A

, et al.

Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice

.

Allergy

.

2016

Jul

;

71

(

7

):

944

–

56

.

[PubMed]

1398-9995

17.

Mimura

T

,

Ueda

Y

,

Watanabe

Y

,

Sugiura

T

.

The cannabinoid receptor-2 is involved in allergic inflammation

.

Life Sci

.

2012

Jun

;

90

(

21-22

):

862

–

6

.

[PubMed]

1879-0631

18.

Pandey

R

,

Mousawy

K

,

Nagarkatti

M

,

Nagarkatti

P

.

Endocannabinoids and immune regulation

.

Pharmacol Res

.

2009

Aug

;

60

(

2

):

85

–

92

.

[PubMed]

1096-1186

19.

Fernández-Ruiz

J

.

The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes

.

Br J Pharmacol

.

2019

May

;

176

(

10

):

1370

–

83

.

[PubMed]

1476-5381

20.

Toczek

M

,

Malinowska

B

.

Enhanced endocannabinoid tone as a potential target of pharmacotherapy

.

Life Sci

.

2018

Jul

;

204

:

20

–

45

.

[PubMed]

1879-0631

21.

Pertwee

RG

.

Endocannabinoids and Their Pharmacological Actions

.

Handb Exp Pharmacol

.

2015

;

231

:

1

–

37

.

[PubMed]

0171-2004

22.

De Petrocellis

L

,

Di Marzo

V

.

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels

.

J Neuroimmune Pharmacol

.

2010

Mar

;

5

(

1

):

103

–

21

.

[PubMed]

1557-1904

23.

Maccarrone

M

,

Bab

I

,

Bíró

T

,

Cabral

GA

,

Dey

SK

,

Di Marzo

V

, et al.

Endocannabinoid signaling at the periphery: 50 years after THC

.

Trends Pharmacol Sci

.

2015

May

;

36

(

5

):

277

–

96

.

[PubMed]

1873-3735

24.

Pisanti

S

,

Malfitano

AM

,

Ciaglia

E

,

Lamberti

A

,

Ranieri

R

,

Cuomo

G

, et al.

Cannabidiol: state of the art and new challenges for therapeutic applications

.

Pharmacol Ther

.

2017

Jul

;

175

:

133

–

50

.

[PubMed]

1879-016X

25.

Hourani

W

,

Alexander

SP

.

Cannabinoid ligands, receptors and enzymes: pharmacological tools and therapeutic potential

.

Brain Neurosci Adv

.

2018

Jun

;

2

:

2398212818783908

.

[PubMed]

2398-2128

26.

Pertwee

RG

.

The pharmacology of cannabinoid receptors and their ligands: an overview

.

Int J Obes (Lond)

.

2006

Apr

;

30

Suppl 1

:

S13

–

8

.

[PubMed]

0307-0565

27.

Maccarrone

M

,

Dainese

E

,

Oddi

S

.

Intracellular trafficking of anandamide: new concepts for signaling

.

Trends Biochem Sci

.

2010

Nov

;

35

(

11

):

601

–

8

.

[PubMed]

0968-0004

28.

Maccarrone

M

.

Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years

.

Front Mol Neurosci

.

2017

May

;

10

:

166

.

[PubMed]

1662-5099

29.

Chicca

A

,

Marazzi

J

,

Nicolussi

S

,

Gertsch

J

.

Evidence for bidirectional endocannabinoid transport across cell membranes

.

J Biol Chem

.

2012

Oct

;

287

(

41

):

34660

–

82

.

[PubMed]

1083-351X

30.

Deng

H

,

Li

W

.

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

.

Acta Pharm Sin B

.

2020

Apr

;

10

(

4

):

582

–

602

.

[PubMed]

2211-3835

31.

Celorrio

M

,

Fernández-Suárez

D

,

Rojo-Bustamante

E

,

Echeverry-Alzate

V

,

Ramírez

MJ

,

Hillard

CJ

, et al.

Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson’s disease

.

Brain Behav Immun

.

2016

Oct

;

57

:

94

–

105

.

[PubMed]

1090-2139

32.

Gil-Ordóñez

A

,

Martín-Fontecha

M

,

Ortega-Gutiérrez

S

,

López-Rodríguez

ML

.

Monoacylglycerol lipase (MAGL) as a promising therapeutic target

.

Biochem Pharmacol

.

2018

Nov

;

157

:

18

–

32

.

[PubMed]

1873-2968

33.

Hua

T

,

Vemuri

K

,

Pu

M

,

Qu

L

,

Han

GW

,

Wu

Y

, et al.

Crystal Structure of the Human Cannabinoid Receptor CB1.

Cell.

2016

;167(3):750-62 e14.

34.

Shao

Z

,

Yin

J

,

Chapman

K

,

Grzemska

M

,

Clark

L

,

Wang

J

, et al.

High-resolution crystal structure of the human CB1 cannabinoid receptor

.

Nature

.

2016

Dec

;

540

(

7634

):

602

–

6

.

[PubMed]

1476-4687

35.

Li

X

,

Hua

T

,

Vemuri

K

,

Ho

JH

,

Wu

Y

,

Wu

L

, et al.

Crystal Structure of the Human Cannabinoid Receptor CB2.

Cell.

2019

;176(3):459-67 e13.

36.

Bonhaus

DW

,

Chang

LK

,

Kwan

J

,

Martin

GR

.

Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses

.

J Pharmacol Exp Ther

.

1998

Dec

;

287

(

3

):

884

–

8

.

[PubMed]

0022-3565

37.

Galve-Roperh

I

,

Chiurchiù

V

,

Díaz-Alonso

J

,

Bari

M

,

Guzmán

M

,

Maccarrone

M

.

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation

.

Prog Lipid Res

.

2013

Oct

;

52

(

4

):

633

–

50

.

[PubMed]

1873-2194

38.

Maccarrone

M

,

Guzmán

M

,

Mackie

K

,

Doherty

P

,

Harkany

T

.

Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies

.

Nat Rev Neurosci

.

2014

Dec

;

15

(

12

):

786

–

801

.

[PubMed]

1471-0048

39.

Liu

QR

,

Pan

CH

,

Hishimoto

A

,

Li

CY

,

Xi

ZX

,

Llorente-Berzal

A

, et al.

Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands

.

Genes Brain Behav

.

2009

Jul

;

8

(

5

):

519

–

30

.

[PubMed]

1601-183X

40.

Van Sickle

MD

,

Duncan

M

,

Kingsley

PJ

,

Mouihate

A

,

Urbani

P

,

Mackie

K

, et al.

Identification and functional characterization of brainstem cannabinoid CB2 receptors

.

Science

.

2005

Oct

;

310

(

5746

):

329

–

32

.

[PubMed]

1095-9203

41.

Massa

F

,

Marsicano

G

,

Hermann

H

,

Cannich

A

,

Monory

K

,

Cravatt

BF

, et al.

The endogenous cannabinoid system protects against colonic inflammation

.

J Clin Invest

.

2004

Apr

;

113

(

8

):

1202

–

9

.

[PubMed]

0021-9738

42.

Romano

B

,

Borrelli

F

,

Fasolino

I

,

Capasso

R

,

Piscitelli

F

,

Cascio

M

, et al.

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis

.

Br J Pharmacol

.

2013

May

;

169

(

1

):

213

–

29

.

[PubMed]

1476-5381

43.

Martin-Fontecha

M

,

Eiwegger

T

,

Jartti

T

,

Rueda-Zubiaurre

A

,

Tiringer

K

,

Stepanow

J

, et al. The expression of cannabinoid receptor 1 is significantly increased in atopic patients. J Allergy Clin Immunol.

2014

;133(3):926-9 e2.

44.

Maresz

K

,

Carrier

EJ

,

Ponomarev

ED

,

Hillard

CJ

,

Dittel

BN

.

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli

.

J Neurochem

.

2005

Oct

;

95

(

2

):

437

–

45

.

[PubMed]

0022-3042

45.

Patel

KD

,

Davison

JS

,

Pittman

QJ

,

Sharkey

KA

.

Cannabinoid CB(2) receptors in health and disease

.

Curr Med Chem

.

2010

;

17

(

14

):

1393

–

410

.

[PubMed]

1875-533X

46.

Sawzdargo

M

,

Nguyen

T

,

Lee

DK

,

Lynch

KR

,

Cheng

R

,

Heng

HH

, et al.

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain

.

Brain Res Mol Brain Res

.

1999

Feb

;

64

(

2

):

193

–

8

.

[PubMed]

0169-328X

47.

Ryberg

E

,

Larsson

N

,

Sjögren

S

,

Hjorth

S

,

Hermansson

NO

,

Leonova

J

, et al.

The orphan receptor GPR55 is a novel cannabinoid receptor

.

Br J Pharmacol

.

2007

Dec

;

152

(

7

):

1092

–

101

.

[PubMed]

0007-1188

48.

Ross

RA

.

The enigmatic pharmacology of GPR55

.

Trends Pharmacol Sci

.

2009

Mar

;

30

(

3

):

156

–

63

.

[PubMed]

0165-6147

49.

Chiurchiù

V

,

Lanuti

M

,

De Bardi

M

,

Battistini

L

,

Maccarrone

M

.

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells

.

Int Immunol

.

2015

Mar

;

27

(

3

):

153

–

60

.

[PubMed]

1460-2377

50.

Stančić

A

,

Jandl

K

,

Hasenöhrl

C

,

Reichmann

F

,

Marsche

G

,

Schuligoi

R

, et al.

The GPR55 antagonist CID16020046 protects against intestinal inflammation

.

Neurogastroenterol Motil

.

2015

Oct

;

27

(

10

):

1432

–

45

.

[PubMed]

1365-2982

51.

Sharir

H

,

Console-Bram

L

,

Mundy

C

,

Popoff

SN

,

Kapur

A

,

Abood

ME

.

The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55

.

J Neuroimmune Pharmacol

.

2012

Dec

;

7

(

4

):

856

–

65

.

[PubMed]

1557-1904

52.

Muller

C

,

Morales

P

,

Reggio

PH

.

Cannabinoid Ligands Targeting TRP Channels

.

Front Mol Neurosci

.

2019

Jan

;

11

:

487

.

[PubMed]

1662-5099

53.

Storozhuk

MV

,

Zholos

AV

.

TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling

.

Curr Neuropharmacol

.

2018

Jan

;

16

(

2

):

137

–

50

.

[PubMed]

1875-6190

54.

De Petrocellis

L

,

Ligresti

A

,

Moriello

AS

,

Allarà

M

,

Bisogno

T

,

Petrosino

S

, et al.

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

.

Br J Pharmacol

.

2011

Aug

;

163

(

7

):

1479

–

94

.

[PubMed]

1476-5381

55.

O’Sullivan

SE

.

An update on PPAR activation by cannabinoids

.

Br J Pharmacol

.

2016

Jun

;

173

(

12

):

1899

–

910

.

[PubMed]

1476-5381

56.

O’Sullivan

SE

,

Kendall

DA

.

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease

.

Immunobiology

.

2010

Aug

;

215

(

8

):

611

–

6

.

[PubMed]

1878-3279

57.

Menendez-Gutierrez

MP

,

Roszer

T

,

Ricote

M

.

Biology and therapeutic applications of peroxisome proliferator- activated receptors

.

Curr Top Med Chem

.

2012

;

12

(

6

):

548

–

84

.

[PubMed]

1873-4294

58.

Hegde

VL

,

Singh

UP

,

Nagarkatti

PS

,

Nagarkatti

M

.

Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo

.

J Immunol

.

2015

Jun

;

194

(

11

):

5211

–

22

.

[PubMed]

1550-6606

59.

Fakhfouri

G

,

Ahmadiani

A

,

Rahimian

R

,

Grolla

AA

,

Moradi

F

,

Haeri

A

.

WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway

.

Neuropharmacology

.

2012

Sep

;

63

(

4

):

653

–

66

.

[PubMed]

1873-7064

60.

Chiurchiù

V

,

Battistini

L

,

Maccarrone

M

.

Endocannabinoid signalling in innate and adaptive immunity

.

Immunology

.

2015

Mar

;

144

(

3

):

352

–

64

.

[PubMed]

1365-2567

61.

Correa

F

,

Docagne

F

,

Clemente

D

,

Mestre

L

,

Becker

C

,

Guaza

C

.

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2)

.

Biochem J

.

2008

Feb

;

409

(

3

):

761

–

70

.

[PubMed]

1470-8728

62.

Fitzpatrick

JM

,

Minogue

E

,

Curham

L

,

Tyrrell

H

,

Gavigan

P

,

Hind

W

, et al.

MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ⁹-tetrahydrocannabinol and cannabidiol in human macrophages

.

J Neuroimmunol

.

2020

Jun

;

343

:

577217

.

[PubMed]

1872-8421

63.

Chiurchiù

V

,

Rapino

C

,

Talamonti

E

,

Leuti

A

,

Lanuti

M

,

Gueniche

A

, et al.

Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes

.

J Immunol

.

2016

Nov

;

197

(

9

):

3545

–

53

.

[PubMed]

1550-6606

64.

Matias

I

,

Pochard

P

,

Orlando

P

,

Salzet

M

,

Pestel

J

,

Di Marzo

V

.

Presence and regulation of the endocannabinoid system in human dendritic cells

.

Eur J Biochem

.

2002

Aug

;

269

(

15

):

3771

–

8

.

[PubMed]

0014-2956

65.

Chiurchiù

V

,

Cencioni

MT

,

Bisicchia

E

,

De Bardi

M

,

Gasperini

C

,

Borsellino

G

, et al.

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

.

Ann Neurol

.

2013

May

;

73

(

5

):

626

–

36

.

[PubMed]

1531-8249

66.

Henriquez

JE

,

Crawford

RB

,

Kaminski

NE

.

Suppression of CpG-ODN-mediated IFNα and TNFα response in human plasmacytoid dendritic cells (pDC) by cannabinoid receptor 2 (CB2)-specific agonists

.

Toxicol Appl Pharmacol

.

2019

Apr

;

369

:

82

–

9

.

[PubMed]

1096-0333

67.

Karmaus

PW

,

Chen

W

,

Crawford

R

,

Kaplan

BL

,

Kaminski

NE

.

Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2

.

Toxicol Sci

.

2013

Feb

;

131

(

2

):

419

–

33

.

[PubMed]

1096-0929

68.

Do

Y

,

McKallip

RJ

,

Nagarkatti

M

,

Nagarkatti

PS

.

Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation

.

J Immunol

.

2004

Aug

;

173

(

4

):

2373

–

82

.

[PubMed]

0022-1767

69.

Kapellos

TS

,

Taylor

L

,

Feuerborn

A

,

Valaris

S

,

Hussain

MT

,

Rainger

GE

, et al.

Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment

.

FASEB J

.

2019

May

;

33

(

5

):

6154

–

67

.

[PubMed]

1530-6860

70.

Zhou

X

,

Yang

L

,

Fan

X

,

Zhao

X

,

Chang

N

,

Yang

L

, et al.

Neutrophil Chemotaxis and NETosis in Murine Chronic Liver Injury via Cannabinoid Receptor 1/ Gα_i/o/ ROS/ p38 MAPK Signaling Pathway

.

Cells

.

2020

Feb

;

9

(

2

):

E373

.

[PubMed]

2073-4409

71.

Chouinard

F

,

Turcotte

C

,

Guan

X

,

Larose

MC

,

Poirier

S

,

Bouchard

L

, et al.

2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV

.

J Leukoc Biol

.

2013

Feb

;

93

(

2

):

267

–

76

.

[PubMed]

1938-3673

72.

Massi

P

,

Fuzio

D

,

Viganò

D

,

Sacerdote

P

,

Parolaro

D

.

Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity

.

Eur J Pharmacol

.

2000

Jan

;

387

(

3

):

343

–

7

.

[PubMed]

0014-2999

73.

Sugawara

K

,

Biro

T

,

Tsuruta

D

,

Toth

BI

,

Kromminga

A

,

Zakany

N

, et al. Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol.

2012

;129(3):726-38 e8.

74.

Ferrini

ME

,

Hong

S

,

Stierle

A

,

Stierle

D

,

Stella

N

,

Roberts

K

, et al.

CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma

.

Allergy

.

2017

Jun

;

72

(

6

):

937

–

47

.

[PubMed]

1398-9995

75.

Henriquez

JE

,

Bach

AP

,

Matos-Fernandez

KM

,

Crawford

RB

,

Kaminski

NE

.

Δ⁹-Tetrahydrocannabinol (THC) Impairs CD8⁺ T Cell-Mediated Activation of Astrocytes

.

J Neuroimmune Pharmacol

.

2020

Mar

.

[PubMed]

1557-1904

76.

Martín-Fontecha

M

,

Angelina

A

,

Rückert

B

,

Rueda-Zubiaurre

A

,

Martín-Cruz

L

,

van de Veen

W

, et al.

A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB₁ in Human Blood and Tonsil Immune System Cells

.

Bioconjug Chem

.

2018

Feb

;

29

(

2

):

382

–

9

.

[PubMed]

1520-4812

77.

Dhital

S

,

Stokes

JV

,

Park

N

,

Seo

KS

,

Kaplan

BL

.

Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation

.

Cell Immunol

.

2017

Feb

;

312

:

25

–

34

.

[PubMed]

1090-2163

78.

Pereira

JP

,

An

J

,

Xu

Y

,

Huang

Y

,

Cyster

JG

.

Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids

.

Nat Immunol

.

2009

Apr

;

10

(

4

):

403

–

11

.

[PubMed]

1529-2916

79.

Muppidi

JR

,

Arnon

TI

,

Bronevetsky

Y

,

Veerapen

N

,

Tanaka

M

,

Besra

GS

, et al.

Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone

.

J Exp Med

.

2011

Sep

;

208

(

10

):

1941

–

8

.

[PubMed]

1540-9538

80.

De Nardo

D

.

Toll-like receptors: Activation, signalling and transcriptional modulation

.

Cytokine

.

2015

Aug

;

74

(

2

):

181

–

9

.

[PubMed]

1096-0023

81.

Rajan

TS

,

Giacoppo

S

,

Iori

R

,

De Nicola

GR

,

Grassi

G

,

Pollastro

F

, et al.

Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages

.

Fitoterapia

.

2016

Jul

;

112

:

104

–

15

.

[PubMed]

1873-6971

82.

McCoy

KL

.

Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation

.

Mediators Inflamm

.

2016

;

2016

:

5831315

.

[PubMed]

1466-1861

83.

Fitzpatrick

JK

,

Downer

EJ

.

Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.

Neuropharmacology.

2017

;113(Pt B):618-26.

84.

van Niekerk

G

,

Mabin

T

,

Engelbrecht

AM

.

Anti-inflammatory mechanisms of cannabinoids: an immunometabolic perspective

.

Inflammopharmacology

.

2019

Feb

;

27

(

1

):

39

–

46

.

[PubMed]

1568-5608

85.

Kelly

B

,

O’Neill

LA

.

Metabolic reprogramming in macrophages and dendritic cells in innate immunity

.

Cell Res

.

2015

Jul

;

25

(

7

):

771

–

84

.

[PubMed]

1748-7838

86.

O’Neill

LA

,

Kishton

RJ

,

Rathmell

J

.

A guide to immunometabolism for immunologists

.

Nat Rev Immunol

.

2016

Sep

;

16

(

9

):

553

–

65

.

[PubMed]

1474-1741

87.

O’Neill

LA

,

Pearce

EJ

.

Immunometabolism governs dendritic cell and macrophage function

.

J Exp Med

.

2016

Jan

;

213

(

1

):

15

–

23

.

[PubMed]

1540-9538

88.

Mihaylova

MM

,

Shaw

RJ

.

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

.

Nat Cell Biol

.

2011

Sep

;

13

(

9

):

1016

–

23

.

[PubMed]

1476-4679

89.

O’Neill

LA

,

Hardie

DG

.

Metabolism of inflammation limited by AMPK and pseudo-starvation

.

Nature

.

2013

Jan

;

493

(

7432

):

346

–

55

.

[PubMed]

1476-4687

90.

Dando

I

,

Donadelli

M

,

Costanzo

C

,

Dalla Pozza

E

,

D’Alessandro

A

,

Zolla

L

, et al.

Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells

.

Cell Death Dis

.

2013

Jun

;

4

:

e664

.

[PubMed]

2041-4889

91.

Vara

D

,

Salazar

M

,

Olea-Herrero

N

,

Guzmán

M

,

Velasco

G

,

Díaz-Laviada

I

.

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy

.

Cell Death Differ

.

2011

Jul

;

18

(

7

):

1099

–

111

.

[PubMed]

1476-5403

92.

Riffelmacher

T

,

Richter

FC

,

Simon

AK

.

Autophagy dictates metabolism and differentiation of inflammatory immune cells

.

Autophagy

.

2018

;

14

(

2

):

199

–

206

.

[PubMed]

1554-8635

93.

Wei

J

,

Long

L

,

Yang

K

,

Guy

C

,

Shrestha

S

,

Chen

Z

, et al.

Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis

.

Nat Immunol

.

2016

Mar

;

17

(

3

):

277

–

85

.

[PubMed]

1529-2916

94.

Koay

LC

,

Rigby

RJ

,

Wright

KL

.

Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium

.

Am J Physiol Gastrointest Liver Physiol

.

2014

Jul

;

307

(

2

):

G140

–

8

.

[PubMed]

1522-1547

95.

Katchan

V

,

David

P

,

Shoenfeld

Y

.

Cannabinoids and autoimmune diseases: A systematic review

.

Autoimmun Rev

.

2016

Jun

;

15

(

6

):

513

–

28

.

[PubMed]

1873-0183

96.

Simon

HU

,

Yousefi

S

,

Germic

N

,

Arnold

IC

,

Haczku

A

,

Karaulov

AV

, et al.

The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020

.

Int Arch Allergy Immunol

.

2020

;

181

(

1

):

11

–

23

.

[PubMed]

1423-0097

97.

Palomares

O

,

Martín-Fontecha

M

,

Lauener

R

,

Traidl-Hoffmann

C

,

Cavkaytar

O

,

Akdis

M

, et al.

Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β

.

Genes Immun

.

2014

Dec

;

15

(

8

):

511

–

20

.

[PubMed]

1476-5470

98.

Gaffal

E

,

Cron

M

,

Glodde

N

,

Bald

T

,

Kuner

R

,

Zimmer

A

, et al.

Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation

.

J Immunol

.

2013

May

;

190

(

10

):

4929

–

36

.

[PubMed]

1550-6606

99.

Vuolo

F

,

Abreu

SC

,

Michels

M

,

Xisto

DG

,

Blanco

NG

,

Hallak

JE

, et al.

Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma

.

Eur J Pharmacol

.

2019

Jan

;

843

:

251

–

9

.

[PubMed]

1879-0712

100.

Mimura

T

,

Oka

S

,

Koshimoto

H

,

Ueda

Y

,

Watanabe

Y

,

Sugiura

T

.

Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation

.

Int Arch Allergy Immunol

.

2012

;

159

(

2

):

149

–

56

.

[PubMed]

1423-0097

101.

Vandenplas

O

,

Suarthana

E

,

Rifflart

C

,

Lemiere

C

,

Le Moual

N

,

Bousquet

J.

The Impact of Work-Related Rhinitis on Quality of Life and Work Productivity: A General Workforce-Based Survey. J Allergy Clin Immunol Pract.

2020

;8(5):1583-91 e5.

102.

Hellings

PW

,

Fokkens

WJ

,

Bachert

C

,

Akdis

CA

,

Bieber

T

,

Agache

I

, et al.;

ARIA and EPOS working groups

.

Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

.

Allergy

.

2017

Sep

;

72

(

9

):

1297

–

305

.

[PubMed]

1398-9995

103.

Sugawara

K

,

Zákány

N

,

Hundt

T

,

Emelianov

V

,

Tsuruta

D

,

Schäfer

C

, et al.

Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ

.

J Allergy Clin Immunol

.

2013

Jul

;

132

(

1

):

182

–

93

.

[PubMed]

1097-6825

104.

Alenmyr

L

,

Högestätt

ED

,

Zygmunt

PM

,

Greiff

L

.

TRPV1-mediated itch in seasonal allergic rhinitis

.

Allergy

.

2009

May

;

64

(

5

):

807

–

10

.

[PubMed]

1398-9995

105.

Wenzel

SE

.

Asthma phenotypes: the evolution from clinical to molecular approaches

.

Nat Med

.

2012

May

;

18

(

5

):

716

–

25

.

[PubMed]

1546-170X

106.

Global Initiative for Asthma

.

Global Strategy for Asthma Management and Prevention.

2020

.

107.

Colodenco

D

,

Palomares

O

,

Celis

C

,

Kaplan

A

,

Domingo

C

.

Moving toward consensus on diagnosis and management of severe asthma in adults

.

Curr Med Res Opin

.

2018

Mar

;

34

(

3

):

387

–

99

.

[PubMed]

1473-4877

108.

Palomares

Ó

,

Sánchez-Ramón

S

,

Dávila

I

,

Prieto

L

,

Pérez de Llano

L

,

Lleonart

M

, et al.

dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies

.

Int J Mol Sci

.

2017

Jun

;

18

(

6

):

E1328

.

[PubMed]

1422-0067

109.

Agache

I

,

Beltran

J

,

Akdis

C

,

Akdis

M

,

Canelo-Aybar

C

,

Canonica

GW

, et al.

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

.

Allergy

.

2020

May

;

75

(

5

):

1023

–

42

.

[PubMed]

1398-9995

110.

Agache

I

,

Rocha

C

,

Beltran

J

,

Song

Y

,

Posso

M

,

Solà

I

, et al.

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

.

Allergy

.

2020

May

;

75

(

5

):

1043

–

57

.

[PubMed]

1398-9995

111.

Agache

I

,

Song

Y

,

Rocha

C

,

Beltran

J

,

Posso

M

,

Steiner

C

, et al.

Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

.

Allergy

.

2020

.0105-4538

112.

Vachon

L

,

FitzGerald

MX

,

Solliday

NH

,

Gould

IA

,

Gaensler

EA

.

Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects

.

N Engl J Med

.

1973

May

;

288

(

19

):

985

–

9

.

[PubMed]

0028-4793

113.

Tashkin

DP

,

Reiss

S

,

Shapiro

BJ

,

Calvarese

B

,

Olsen

JL

,

Lodge

JW

.

Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects

.

Am Rev Respir Dis

.

1977

Jan

;

115

(

1

):

57

–

65

.

[PubMed]

0003-0805

114.

Zoerner

AA

,

Stichtenoth

DO

,

Engeli

S

,

Batkai

S

,

Winkler

C

,

Schaumann

F

, et al.

Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma

.

Clin Pharmacol Ther

.

2011

Sep

;

90

(

3

):

388

–

91

.

[PubMed]

1532-6535

115.

Roviezzo

F

,

Rossi

A

,

Caiazzo

E

,

Orlando

P

,

Riemma

MA

,

Iacono

VM

, et al.

Palmitoylethanolamide Supplementation during Sensitization Prevents Airway Allergic Symptoms in the Mouse

.

Front Pharmacol

.

2017

Dec

;

8

:

857

.

[PubMed]

1663-9812

116.

Stengel

PW

,

Cockerham

SL

,

Silbaugh

SA

.

Inhaled anandamide reduces leukotriene D4-induced airway obstruction in guinea pigs

.

Eur J Pharmacol

.

2007

Feb

;

557

(

1

):

66

–

8

.

[PubMed]

0014-2999

117.

Calignano

A

,

Kátona

I

,

Désarnaud

F

,

Giuffrida

A

,

La Rana

G

,

Mackie

K

, et al.

Bidirectional control of airway responsiveness by endogenous cannabinoids

.

Nature

.

2000

Nov

;

408

(

6808

):

96

–

101

.

[PubMed]

0028-0836

118.

Abboud

RT

,

Sanders

HD

.

Effect of oral administration of delta-tetrahydrocannabinol on airway mechanics in normal and asthmatic subjects

.

Chest

.

1976

Oct

;

70

(

4

):

480

–

5

.

[PubMed]

0012-3692

119.

Bozkurt

TE

,

Kaya

Y

,

Durlu-Kandilci

NT

,

Onder

S

,

Sahin-Erdemli

I

.

The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice

.

Respir Physiol Neurobiol

.

2016

Sep

;

231

:

7

–

13

.

[PubMed]

1878-1519

120.

Grassin-Delyle

S

,

Naline

E

,

Buenestado

A

,

Faisy

C

,

Alvarez

JC

,

Salvator

H

, et al.

Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors

.

Br J Pharmacol

.

2014

Jun

;

171

(

11

):

2767

–

77

.

[PubMed]

1476-5381

121.

Fukuda

H

,

Abe

T

,

Yoshihara

S

.

The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways

.

Int Arch Allergy Immunol

.

2010

;

152

(

3

):

295

–

300

.

[PubMed]

1423-0097

122.

Yoshihara

S

,

Morimoto

H

,

Ohori

M

,

Yamada

Y

,

Abe

T

,

Arisaka

O

.

Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways

.

Int Arch Allergy Immunol

.

2005

Sep

;

138

(

1

):

80

–

7

.

[PubMed]

1018-2438

123.

Bozkurt

TE

.

Endocannabinoid System in the Airways

.

Molecules

.

2019

Dec

;

24

(

24

):

E4626

.

[PubMed]

1420-3049

124.

Jan

TR

,

Farraj

AK

,

Harkema

JR

,

Kaminski

NE

.

Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice

.

Toxicol Appl Pharmacol

.

2003

Apr

;

188

(

1

):

24

–

35

.

[PubMed]

0041-008X

125.

Giannini

L

,

Nistri

S

,

Mastroianni

R

,

Cinci

L

,

Vannacci

A

,

Mariottini

C

, et al.

Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs

.

J Cell Mol Med

.

2008

Dec

;

12

6A

:

2381

–

94

.

[PubMed]

1582-1838

126.

Ribeiro

A

,

Almeida

VI

,

Costola-de-Souza

C

,

Ferraz-de-Paula

V

,

Pinheiro

ML

,

Vitoretti

LB

, et al.

Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury

.

Immunopharmacol Immunotoxicol

.

2015

Feb

;

37

(

1

):

35

–

41

.

[PubMed]

1532-2513

127.

Abohalaka

R

,

Bozkurt

TE

,

Nemutlu

E

,

Onder

SC

,

Sahin-Erdemli

I

.

The Effects of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibitor treatments on Lipopolysaccharide-induced Airway Inflammation in Mice

.

Pulm Pharmacol Ther

.

2020

May

;

•••

:

101920

.

[PubMed]

1522-9629

128.

Benito-Villalvilla

C

,

Soria

I

,

Pérez-Diego

M

,

Fernández-Caldas

E

,

Subiza

JL

,

Palomares

O

.

Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs

.

Allergy

.

2020

Mar

;

75

(

3

):

648

–

59

.

[PubMed]

1398-9995

129.

Benito-Villalvilla

C

,

Soria

I

,

Subiza

JL

,

Palomares

O

.

Novel vaccines targeting dendritic cells by coupling allergoids to mannan

.

Allergo J Int

.

2018

;

27

(

8

):

256

–

62

.

[PubMed]

2197-0378

130.

Sirvent

S

,

Soria

I

,

Cirauqui

C

,

Cases

B

,

Manzano

AI

,

Diez-Rivero

CM

, et al. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. J Allergy Clin Immunol.

2016

;138(2):558-67 e11.

131.

Palladino

C

,

Narzt

MS

,

Bublin

M

,

Schreiner

M

,

Humeniuk

P

,

Gschwandtner

M

, et al.

Peanut lipids display potential adjuvanticity by triggering a pro-inflammatory response in human keratinocytes

.

Allergy

.

2018

Aug

;

73

(

8

):

1746

–

9

.

[PubMed]

1398-9995

132.

Palomares

O.

The role of regulatory T cells in IgE-mediated food allergy. J Investig Allergol Clin Immunol.

2013

;23(6):371-82; quiz 2 p preceding 82.

133.

Ali

A

,

Akhtar

N

.

The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content

.

Pak J Pharm Sci

.

2015

Jul

;

28

(

4

):

1389

–

95

.

[PubMed]

1011-601X

134.

Karsak

M

,

Gaffal

E

,

Date

R

,

Wang-Eckhardt

L

,

Rehnelt

J

,

Petrosino

S

, et al.

Attenuation of allergic contact dermatitis through the endocannabinoid system

.

Science

.

2007

Jun

;

316

(

5830

):

1494

–

7

.

[PubMed]

1095-9203

135.

Avila

C

,

Massick

S

,

Kaffenberger

BH

,

Kwatra

SG

,

Bechtel

M

.

Cannabinoids for the treatment of chronic pruritus: A review

.

J Am Acad Dermatol

.

2020

May

;

82

(

5

):

1205

–

12

.

[PubMed]

1097-6787

136.

López-Abente

J

,

Bernaldo-de-Quirós

E

,

Camino

M

,

Gil

N

,

Panadero

E

,

Campos-Domínguez

M

, et al.

Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart-transplant children: A delicate balance between risk of rejection or atopic symptoms

.

Am J Transplant

.

2019

May

;

19

(

5

):

1536

–

44

.

[PubMed]

1600-6143

137.

Simon

D

,

Wollenberg

A

,

Renz

H

,

Simon

HU

.

Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019

.

Int Arch Allergy Immunol

.

2019

;

178

(

3

):

207

–

18

.

[PubMed]

1423-0097

138.

Gaffal

E

,

Glodde

N

,

Jakobs

M

,

Bald

T

,

Tüting

T

.

Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis

.

Exp Dermatol

.

2014

Jun

;

23

(

6

):

401

–

6

.

[PubMed]

1600-0625

139.

Roelandt

T

,

Heughebaert

C

,

Bredif

S

,

Giddelo

C

,

Baudouin

C

,

Msika

P

, et al.

Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation

.

Exp Dermatol

.

2012

Sep

;

21

(

9

):

688

–

93

.

[PubMed]

1600-0625

140.

Kim

HJ

,

Kim

B

,

Park

BM

,

Jeon

JE

,

Lee

SH

,

Mann

S

, et al.

Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model

.

Int J Dermatol

.

2015

Oct

;

54

(

10

):

e401

–

8

.

[PubMed]

1365-4632

141.

Nam

G

,

Jeong

SK

,

Park

BM

,

Lee

SH

,

Kim

HJ

,

Hong

SP

, et al.

Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model

.

Ann Dermatol

.

2016

Feb

;

28

(

1

):

22

–

9

.

[PubMed]

1013-9087

142.

Small-Howard

AL

,

Shimoda

LM

,

Adra

CN

,

Turner

H

.

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells

.

Biochem J

.

2005

Jun

;

388

(

Pt 2

):

465

–

73

.

[PubMed]

1470-8728

143.

Petrosino

S

,

Cristino

L

,

Karsak

M

,

Gaffal

E

,

Ueda

N

,

Tüting

T

, et al.

Protective role of palmitoylethanolamide in contact allergic dermatitis

.

Allergy

.

2010

Jun

;

65

(

6

):

698

–

711

.

[PubMed]

1398-9995

144.

Ständer

S

,

Reinhardt

HW

,

Luger

TA

.

[Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus]

.

Hautarzt

.

2006

Sep

;

57

(

9

):

801

–

7

.

[PubMed]

0017-8470

145.

Oláh

A

,

Ambrus

L

,

Nicolussi

S

,

Gertsch

J

,

Tubak

V

,

Kemény

L

, et al.

Inhibition of fatty acid amide hydrolase exerts cutaneous anti-inflammatory effects both in vitro and in vivo

.

Exp Dermatol

.

2016

Apr

;

25

(

4

):

328

–

30

.

[PubMed]

1600-0625

146.

Sasso

O

,

Summa

M

,

Armirotti

A

,

Pontis

S

,

De Mei

C

,

Piomelli

D

.

The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis

.

J Invest Dermatol

.

2018

Mar

;

138

(

3

):

562

–

9

.

[PubMed]

1523-1747

147.

Kozela

E

,

Juknat

A

,

Kaushansky

N

,

Ben-Nun

A

,

Coppola

G

,

Vogel

Z

.

Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells

.

J Neuroinflammation

.

2015

Mar

;

12

:

52

.

[PubMed]

1742-2094

148.

Harvey

BS

,

Sia

TC

,

Wattchow

DA

,

Smid

SD

.

Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model

.

Cytokine

.

2014

Feb

;

65

(

2

):

236

–

44

.

[PubMed]

1096-0023

149.

De Filippis

D

,

Esposito

G

,

Cirillo

C

,

Cipriano

M

,

De Winter

BY

,

Scuderi

C

, et al.

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

.

PLoS One

.

2011

;

6

(

12

):

e28159

.

[PubMed]

1932-6203

150.

Lee

WS

,

Erdelyi

K

,

Matyas

C

,

Mukhopadhyay

P

,

Varga

ZV

,

Liaudet

L

, et al.

Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation

.

Mol Med

.

2016

Sep

;

22

:

136

–

46

.

[PubMed]

1528-3658

151.

Tawada

C

,

Kanoh

H

,

Nakamura

M

,

Mizutani

Y

,

Fujisawa

T

,

Banno

Y

, et al.

Interferon-γ decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis

.

J Invest Dermatol

.

2014

Mar

;

134

(

3

):

712

–

8

.

[PubMed]

1523-1747

152.

Palmieri

B

,

Laurino

C

,

Vadalà

M

.

A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars

.

Clin Ter

.

2019

Mar-Apr

;

170

(

2

):

e93

–

9

.

[PubMed]

1972-6007

153.

Haruna

T

,

Soga

M

,

Morioka

Y

,

Imura

K

,

Furue

Y

,

Yamamoto

M

, et al.

The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice

.

Pharmacology

.

2017

;

99

(

5-6

):

259

–

67

.

[PubMed]

1423-0313

154.

Kaplan

DH

,

Igyártó

BZ

,

Gaspari

AA

.

Early immune events in the induction of allergic contact dermatitis

.

Nat Rev Immunol

.

2012

Jan

;

12

(

2

):

114

–

24

.

[PubMed]

1474-1741

155.

Schmidt

M

,

Raghavan

B

,

Müller

V

,

Vogl

T

,

Fejer

G

,

Tchaptchet

S

, et al.

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel

.

Nat Immunol

.

2010

Sep

;

11

(

9

):

814

–

9

.

[PubMed]

1529-2916

156.

Watanabe

H

,

Gaide

O

,

Pétrilli

V

,

Martinon

F

,

Contassot

E

,

Roques

S

, et al.

Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity

.

J Invest Dermatol

.

2007

Aug

;

127

(

8

):

1956

–

63

.

[PubMed]

1523-1747

157.

Engeman

T

,

Gorbachev

AV

,

Kish

DD

,

Fairchild

RL

.

The intensity of neutrophil infiltration controls the number of antigen-primed CD8 T cells recruited into cutaneous antigen challenge sites

.

J Leukoc Biol

.

2004

Nov

;

76

(

5

):

941

–

9

.

[PubMed]

0741-5400

158.

Kish

DD

,

Gorbachev

AV

,

Parameswaran

N

,

Gupta

N

,

Fairchild

RL

.

Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin

.

J Immunol

.

2012

Sep

;

189

(

5

):

2191

–

202

.

[PubMed]

1550-6606

159.

Kish

DD

,

Li

X

,

Fairchild

RL

.

CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge

.

J Immunol

.

2009

May

;

182

(

10

):

5949

–

59

.

[PubMed]

1550-6606

160.

Petrosino

S

,

Verde

R

,

Vaia

M

,

Allarà

M

,

Iuvone

T

,

Di Marzo

V

.

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis

.

J Pharmacol Exp Ther

.

2018

Jun

;

365

(

3

):

652

–

63

.

[PubMed]

1521-0103

161.

Vaia

M

,

Petrosino

S

,

De Filippis

D

,

Negro

L

,

Guarino

A

,

Carnuccio

R

, et al.

Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis

.

Eur J Pharmacol

.

2016

Nov

;

791

:

669

–

74

.

[PubMed]

1879-0712

162.

Sampson

HA

,

O’Mahony

L

,

Burks

AW

,

Plaut

M

,

Lack

G

,

Akdis

CA

.

Mechanisms of food allergy

.

J Allergy Clin Immunol

.

2018

Jan

;

141

(

1

):

11

–

9

.

[PubMed]

1097-6825

163.

Burks

AW

,

Sampson

HA

,

Plaut

M

,

Lack

G

,

Akdis

CA

.

Treatment for food allergy

.

J Allergy Clin Immunol

.

2018

Jan

;

141

(

1

):

1

–

9

.

[PubMed]

1097-6825

164.

Yu

W

,

Freeland

DM

,

Nadeau

KC

.

Food allergy: immune mechanisms, diagnosis and immunotherapy

.

Nat Rev Immunol

.

2016

Dec

;

16

(

12

):

751

–

65

.

[PubMed]

1474-1741

165.

Moreira

FA

,

Grieb

M

,

Lutz

B

.

Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression

.

Best Pract Res Clin Endocrinol Metab

.

2009

Feb

;

23

(

1

):

133

–

44

.

[PubMed]

1878-1594

166.

Morales

P

,

Hernandez-Folgado

L

,

Goya

P

,

Jagerovic

N

. Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update. Expert Opin Ther Pat.

2016

;26(7):843-56.

167.

Marchalant

Y

,

Brownjohn

PW

,

Bonnet

A

,

Kleffmann

T

,

Ashton

JC

.

Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity

.

J Histochem Cytochem

.

2014

Jun

;

62

(

6

):

395

–

404

.

[PubMed]

1551-5044

168.

Grimsey

NL

,

Goodfellow

CE

,

Scotter

EL

,

Dowie

MJ

,

Glass

M

,

Graham

ES

.

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

J Neurosci Methods

.

2008

Jun

;

171

(

1

):

78

–

86

.

[PubMed]

0165-0270

169.

Yates

AS

,

Doughty

SW

,

Kendall

DA

,

Kellam

B

.

Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor

.

Bioorg Med Chem Lett

.

2005

Aug

;

15

(

16

):

3758

–

62

.

[PubMed]

0960-894X

170.

Martín-Couce

L

,

Martín-Fontecha

M

,

Palomares

O

,

Mestre

L

,

Cordomí

A

,

Hernangomez

M

, et al.

Chemical probes for the recognition of cannabinoid receptors in native systems

.

Angew Chem Int Ed Engl

.

2012

Jul

;

51

(

28

):

6896

–

9

.

[PubMed]

1521-3773

171.

Petrov

RR

,

Ferrini

ME

,

Jaffar

Z

,

Thompson

CM

,

Roberts

K

,

Diaz

P

.

Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells

.

Bioorg Med Chem Lett

.

2011

Oct

;

21

(

19

):

5859

–

62

.

[PubMed]

1464-3405

172.

Westphal

MV

,

Sarott

RC

,

Zirwes

EA

,

Osterwald

A

,

Guba

W

,

Ullmer

C

, et al.

Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes

.

Chemistry

.

2020

Jan

;

26

(

6

):

1380

–

7

.

[PubMed]

1521-3765

173.

Soethoudt

M

,

Alachouzos

G

,

van Rooden

EJ

,

Moya-Garzón

MD

,

van den Berg

RJ

,

Heitman

LH

, et al.

Development of a Cannabinoid-Based Photoaffinity Probe to Determine the Δ^8/9-Tetrahydrocannabinol Protein Interaction Landscape in Neuroblastoma Cells

.

Cannabis Cannabinoid Res

.

2018

Jul

;

3

(

1

):

136

–

51

.

[PubMed]

2378-8763

174.

Singh

S

,

Oyagawa

CR

,

Macdonald

C

,

Grimsey

NL

,

Glass

M

,

Vernall

AJ

.

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor

.

ACS Med Chem Lett

.

2019

Jan

;

10

(

2

):

209

–

14

.

[PubMed]

1948-5875

175.

Wu

Z

,

Shao

P

,

Zhang

S

,

Ling

X

,

Bai

M

.

Molecular imaging of human tumor cells that naturally overexpress type 2 cannabinoid receptors using a quinolone-based near-infrared fluorescent probe

.

J Biomed Opt

.

2014

;

19

(

7

):

76016

.

[PubMed]

1560-2281

176.

Kulkarni

PM

,

Kulkarni

AR

,

Korde

A

,

Tichkule

RB

,

Laprairie

RB

,

Denovan-Wright

EM

, et al.

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)

.

J Med Chem

.

2016

Jan

;

59

(

1

):

44

–

60

.

[PubMed]

1520-4804

177.

Blankman

JL

,

Cravatt

BF

.

Chemical probes of endocannabinoid metabolism

.

Pharmacol Rev

.

2013

Mar

;

65

(

2

):

849

–

71

.

[PubMed]

1521-0081

178.

Chicca

A

,

Nicolussi

S

,

Bartholomäus

R

,

Blunder

M

,

Aparisi Rey

A

,

Petrucci

V

, et al.

Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake

.

Proc Natl Acad Sci U S A

.

2017

Jun

;

114

(

25

):

E5006

–

15

.

[PubMed]

1091-6490

179.

Turcotte

C

,

Dumais

É

,

Archambault

AS

,

Martin

C

,

Blanchet

MR

,

Bissonnette

É

, et al.

Human leukocytes differentially express endocannabinoid-glycerol lipases and hydrolyze 2-arachidonoyl-glycerol and its metabolites from the 15-lipoxygenase and cyclooxygenase pathways

.

J Leukoc Biol

.

2019

Dec

;

106

(

6

):

1337

–

47

.

[PubMed]

1938-3673

180.

Hsu

KL

,

Tsuboi

K

,

Adibekian

A

,

Pugh

H

,

Masuda

K

,

Cravatt

BF

.

DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses

.

Nat Chem Biol

.

2012

Dec

;

8

(

12

):

999

–

1007

.

[PubMed]

1552-4469

181.

Shin

M

,

Buckner

A

,

Prince

J

,

Bullock

TNJ

,

Hsu

KL

. Diacylglycerol Lipase-beta Is Required for TNF-alpha Response but Not CD8(+) T Cell Priming Capacity of Dendritic Cells. Cell Chem Biol.

2019

;26(7):1036-41 e3.

182.

Pacher

P

,

Kunos

G

.

Modulating the endocannabinoid system in human health and disease—successes and failures

.

FEBS J

.

2013

May

;

280

(

9

):

1918

–

43

.

[PubMed]

1742-4658

183.

A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis [Available from: https://ClinicalTrials.gov/show/NCT00697710

184.

Chiurchiù

V

,

Lanuti

M

,

Catanzaro

G

,

Fezza

F

,

Rapino

C

,

Maccarrone

M

.

Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor

.

Atherosclerosis

.

2014

Mar

;

233

(

1

):

55

–

63

.

[PubMed]

1879-1484

185.

Staiano

RI

,

Loffredo

S

,

Borriello

F

,

Iannotti

FA

,

Piscitelli

F

,

Orlando

P

, et al.

Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors

.

J Leukoc Biol

.

2016

Apr

;

99

(

4

):

531

–

40

.

[PubMed]

1938-3673

186.

Gallily

R

,

Breuer

A

,

Mechoulam

R

.

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

.

Eur J Pharmacol

.

2000

Oct

;

406

(

1

):

R5

–

7

.

[PubMed]

0014-2999

187.

Chang

YH

,

Lee

ST

,

Lin

WW

.

Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids

.

J Cell Biochem

.

2001

;

81

(

4

):

715

–

23

.

[PubMed]

0730-2312

188.

Shiratsuchi

A

,

Watanabe

I

,

Yoshida

H

,

Nakanishi

Y

.

Involvement of cannabinoid receptor CB2 in dectin-1-mediated macrophage phagocytosis

.

Immunol Cell Biol

.

2008

Feb

;

86

(

2

):

179

–

84

.

[PubMed]

0818-9641

189.

Redlich

S

,

Ribes

S

,

Schütze

S

,

Nau

R

.

Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections

.

J Neuroinflammation

.

2014

Jun

;

11

:

108

.

[PubMed]

1742-2094

190.

Hao

MX

,

Jiang

LS

,

Fang

NY

,

Pu

J

,

Hu

LH

,

Shen

LH

, et al.

The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages

.

J Lipid Res

.

2010

Aug

;

51

(

8

):

2181

–

90

.

[PubMed]

1539-7262

191.

Wu

HY

,

Huang

CH

,

Lin

YH

,

Wang

CC

,

Jan

TR

.

Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production

.

Free Radic Biol Med

.

2018

Aug

;

124

:

311

–

8

.

[PubMed]

1873-4596

192.

Roth

MD

,

Castaneda

JT

,

Kiertscher

SM

.

Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation

.

J Neuroimmune Pharmacol

.

2015

Jun

;

10

(

2

):

333

–

43

.

[PubMed]

1557-1904

193.

Graham

ES

,

Angel

CE

,

Schwarcz

LE

,

Dunbar

PR

,

Glass

M

.

Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry

.

Int J Immunopathol Pharmacol

.

2010

Jan-Mar

;

23

(

1

):

25

–

34

.

[PubMed]

0394-6320

194.

McHugh

D

,

Tanner

C

,

Mechoulam

R

,

Pertwee

RG

,

Ross

RA

.

Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2

.

Mol Pharmacol

.

2008

Feb

;

73

(

2

):

441

–

50

.

[PubMed]

1521-0111

195.

Oka

S

,

Ikeda

S

,

Kishimoto

S

,

Gokoh

M

,

Yanagimoto

S

,

Waku

K

, et al.

2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils

.

J Leukoc Biol

.

2004

Nov

;

76

(

5

):

1002

–

9

.

[PubMed]

0741-5400

196.

Kishimoto

S

,

Oka

S

,

Gokoh

M

,

Sugiura

T

.

Chemotaxis of human peripheral blood eosinophils to 2-arachidonoylglycerol: comparison with other eosinophil chemoattractants

.

Int Arch Allergy Immunol

.

2006

;

140

Suppl 1

:

3

–

7

.

[PubMed]

1018-2438

197.

Hernández-Cervantes

R

,

Pérez-Torres

A

,

Prospéro-García

Ó

,

Morales Montor

J

.

Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response

.

Sci Rep

.

2019

Dec

;

9

(

1

):

20340

.

[PubMed]

2045-2322

198.

Facci

L

,

Dal Toso

R

,

Romanello

S

,

Buriani

A

,

Skaper

SD

,

Leon

A

.

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

.

Proc Natl Acad Sci U S A

.

1995

Apr

;

92

(

8

):

3376

–

80

.

[PubMed]

0027-8424

199.

Cruz

SL

,

Sánchez-Miranda

E

,

Castillo-Arellano

JI

,

Cervantes-Villagrana

RD

,

Ibarra-Sánchez

A

,

González-Espinosa

C

.

Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB₂ and GPR55 receptor activation. Possible involvement of CB₂-GPR55 heteromers

.

Int Immunopharmacol

.

2018

Nov

;

64

:

298

–

307

.

[PubMed]

1878-1705

200.

Baban

B

,

Khodadadi

H

,

Vaibhav

K

,

Marchetti

C

,

Riccardi

C

,

Mozaffari

MS

.

Regulation of Innate Lymphoid Cells in Acute Kidney Injury: crosstalk between Cannabidiol and GILZ

.

J Immunol Res

.

2020

Feb

;

2020

:

6056373

.

[PubMed]

2314-7156

201.

Cencioni

MT

,

Chiurchiù

V

,

Catanzaro

G

,

Borsellino

G

,

Bernardi

G

,

Battistini

L

, et al.

Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors

.

PLoS One

.

2010

Jan

;

5

(

1

):

e8688

.

[PubMed]

1932-6203

202.

Robinson

RH

,

Meissler

JJ

,

Breslow-Deckman

JM

,

Gaughan

J

,

Adler

MW

,

Eisenstein

TK

.

Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction

.

J Neuroimmune Pharmacol

.

2013

Dec

;

8

(

5

):

1239

–

50

.

[PubMed]

1557-1904

203.

Maresz

K

,

Pryce

G

,

Ponomarev

ED

,

Marsicano

G

,

Croxford

JL

,

Shriver

LP

, et al.

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

.

Nat Med

.

2007

Apr

;

13

(

4

):

492

–

7

.

[PubMed]

1078-8956

204.

Gentili

M

,

Ronchetti

S

,

Ricci

E

,

Di Paola

R

,

Gugliandolo

E

,

Cuzzocrea

S

, et al.

Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease

.

Pharmacol Res

.

2019

Mar

;

141

:

21

–

31

.

[PubMed]

1096-1186

205.

Galiègue

S

,

Mary

S

,

Marchand

J

,

Dussossoy

D

,

Carrière

D

,

Carayon

P

, et al.

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

.

Eur J Biochem

.

1995

Aug

;

232

(

1

):

54

–

61

.

[PubMed]

0014-2956

206.

Derocq

JM

,

Ségui

M

,

Marchand

J

,

Le Fur

G

,

Casellas

P

.

Cannabinoids enhance human B-cell growth at low nanomolar concentrations

.

FEBS Lett

.

1995

Aug

;

369

(

2-3

):

177

–

82

.

[PubMed]

0014-5793

207.

Agudelo

M

,

Newton

C

,

Widen

R

,

Sherwood

T

,

Nong

L

,

Friedman

H

, et al.

Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes

.

J Neuroimmune Pharmacol

.

2008

Mar

;

3

(

1

):

35

–

42

.

[PubMed]

1557-1904

208.

Soethoudt

M

,

Stolze

SC

,

Westphal

MV

,

van Stralen

L

,

Martella

A

,

van Rooden

EJ

, et al.

Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB₂ Receptor Expression and Ligand Engagement in Human Cells

.

J Am Chem Soc

.

2018

May

;

140

(

19

):

6067

–

75

.

[PubMed]

1520-5126

209.

Hsu

KL

,

Tsuboi

K

,

Whitby

LR

,

Speers

AE

,

Pugh

H

,

Inloes

J

, et al.

Development and optimization of piperidyl-1,2,3-triazole ureas as selective chemical probes of endocannabinoid biosynthesis

.

J Med Chem

.

2013

Nov

;

56

(

21

):

8257

–

69

.

[PubMed]

1520-4804

210.

Baggelaar

MP

,

Janssen

FJ

,

van Esbroeck

AC

,

den Dulk

H

,

Allarà

M

,

Hoogendoorn

S

, et al.

Development of an activity-based probe and in silico design reveal highly selective inhibitors for diacylglycerol lipase-α in brain

.

Angew Chem Int Ed Engl

.

2013

Nov

;

52

(

46

):

12081

–

5

.

[PubMed]

1521-3773

211.

Miceli

M

,

Casati

S

,

Ottria

R

,

Di Leo

S

,

Eberini

I

,

Palazzolo

L

, et al.

Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe

.

Molecules

.

2019

Jun

;

24

(

12

):

E2241

.

[PubMed]

1420-3049

212.

Liu

Y

,

Patricelli

MP

,

Cravatt

BF

.

Activity-based protein profiling: the serine hydrolases

.

Proc Natl Acad Sci U S A

.

1999

Dec

;

96

(

26

):

14694

–

9

.

[PubMed]

0027-8424

213.

Janssen

AP

,

van der Vliet

D

,

Bakker

AT

,

Jiang

M

,

Grimm

SH

,

Campiani

G

, et al.

Development of a Multiplexed Activity-Based Protein Profiling Assay to Evaluate Activity of Endocannabinoid Hydrolase Inhibitors

.

ACS Chem Biol

.

2018

Sep

;

13

(

9

):

2406

–

13

.

[PubMed]

1554-8937